购物车
您的购物车当前为空
(±)7(8)-DiHDPA is a major metabolite of docosahexaenoic acid that is produced via oxidation by cytochrome P450 epoxygenases. Epoxygenase metabolites of DHA, including (±)7(8)-DiHDPA, suppress aggregation and thromboxane synthesis in isolated platelets.

(±)7(8)-DiHDPA is a major metabolite of docosahexaenoic acid that is produced via oxidation by cytochrome P450 epoxygenases. Epoxygenase metabolites of DHA, including (±)7(8)-DiHDPA, suppress aggregation and thromboxane synthesis in isolated platelets.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 50 μg | ¥ 2,130 | 35日内发货 | |
| 100 μg | ¥ 3,660 | 35日内发货 | |
| 500 μg | ¥ 14,300 | 35日内发货 | |
| 1 mg | ¥ 23,600 | 35日内发货 |
| 产品描述 | (±)7(8)-DiHDPA is a major metabolite of docosahexaenoic acid that is produced via oxidation by cytochrome P450 epoxygenases. Epoxygenase metabolites of DHA, including (±)7(8)-DiHDPA, suppress aggregation and thromboxane synthesis in isolated platelets. |
| 分子量 | 362.51 |
| 分子式 | C22H34O4 |
| CAS No. | 168111-93-1 |
| Smiles | CC\C=C/C\C=C/C\C=C/C\C=C/C[C@@H](O)[C@H](O)C\C=C/CCC(O)=O |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度信息 | DMF: 50 mg/mL (137.93 mM), Sonication is recommended. DMSO: 50 mg/mL (137.93 mM), Sonication is recommended. Ethanol: 50 mg/mL (137.93 mM), Sonication is recommended. PBS (pH 7.2): 0.25 mg/mL (0.69 mM), Sonication is recommended. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多